A case of recurrent vulvar carcinoma treated with erlotinib, an EGER inhibitor.

Authors :: Bacha, O. M.
Levesque, E.
Renaud, M. C.
Lalancette, M.
Source :: European Journal of Gynaecological Oncology. 2011, Vol. 32 Issue 4, p423-424. 2p.
Publication Year :: 2011
Abstract: The article presents a case study of a 67-year-old woman who was referred for an invasive squamous cell carcinoma (SCC) on her right perineum, which was operated upon. It discusses the use of Erlotinib, an epithelial growth factor receptor (EGFR) inhibitor, in the case of recurrent vulvar cancer. Use of the erlotinib was seen with rapid clinical improvement with palliation of symptoms but later on with the occurrence of Dyspnea.